A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.

NCT00576303 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche